Cordis, Boston Sci. Infringed Stents: Fed. Circ.

Law360, New York (March 31, 2009, 12:00 AM EDT) -- In a long-running intellectual property battle over intravascular stents, the U.S. Court of Appeals for the Federal Circuit has largely stood behind a judgment that both Boston Scientific Corp. and Cordis Corp. have infringed certain patent elements, and further closed the door on a claim by Cordis over Boston Scientific’s Taxus Liberte stent by dismissing it with prejudice.

On Tuesday, a three-judge panel of the Federal Circuit issued an opinion affirming virtually all the findings in the U.S. District Court for the District of Delaware in...
To view the full article, register now.